Abiraterone’s approval is great news for men with prostate cancer – but why did it take so long? 29 Mar 2016 Professor Paul Workman comments on the recent decision by NICE to approve abiraterone for men with advanced prostate cancer and offers thoughts on the drug approval process. Find out more Show/Hide